How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Background. Direct-acting antivirals (DAAs) against hepatitis C virus (HCV) have been described as revolutionary. However, it remains uncertain how effective these drugs will be for individuals coinfected with human immunodeficiency virus (HIV)–HCV. Bridging this gap between efficacy and effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Sahar, Strumpf, Erin C., Walmsley, Sharon L., Rollet-Kurhajec, Kathleen, Pick, Neora, Martel-Laferrière, Valerie, Hull, Mark, Gill, M. John, Cox, Joseph, Cooper, Curtis, Klein, Marina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787608/
https://www.ncbi.nlm.nih.gov/pubmed/26743093
http://dx.doi.org/10.1093/cid/civ1222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787608/
https://www.ncbi.nlm.nih.gov/pubmed/26743093
http://dx.doi.org/10.1093/cid/civ1222

Ejemplares similares